Continuation and Expansion of the National Mesothelioma Virtual Bank for Translational Research (U24)
View forecast on Grants.gov →Forecasted — not yet open
- Posted
- July 22, 2026
- Closes
- See announcement
- Award ceiling
- $1,100,000
- Award floor
- $750,000
- Program funding
- $5,500,000
- Expected awards
- 1
- Cost sharing
- No
- Instrument
- Cooperative Agreement
- Assistance listing
- 93.262
- Category
- Health
- Archives
- April 28, 2028
Program funding history
Awards made under Assistance Listing 93.262 across FY2024–FY2026, from public federal spending records.
- FY2024 obligated
- $107.1M
- FY2025 obligated
- $105M
- FY2026 (to date) obligated
- $33M
- Awards in window
- 326
Top recipients: City of New York, The University of Iowa, University of Illinois, Cpwr: the Center for Construction Research and Training, University of North Carolina at Chapel Hill
Source: USAspending.gov · refreshed August 2026
Synopsis
The National Mesothelioma Virtual Bank (NMVB) was established in 2006 to serve as a resource for malignant mesothelioma research. This funding opportunity will advance biomedical research for malignant mesothelioma by adding more biospecimens together with demographic data and clinical data.
Examples of biospecimens include fresh frozen tumor and control tissues, paraffin embedded tissues, blood, DNA, RNA, and protein samples from mesothelioma patients. Demographic data includes age, sex, race, and occupational history. Clinical data includes stage, treatment, and survival information.
The virtual registry and tissue bank also serve as a virtual repository and offer a library of biospecimens and data that investigators can use and share, including genomic, transcriptomic, and proteomic data.
The NMVB can:
- Help identify early signs of disease.
- Support the development of biomarkers that show disease stage and prognosis.
- Help develop new or improved treatment options.
The goal is to continue to expand the NMVB and improve its ability to be a resource for both biomedical researchers and the clinical science community focused on malignant mesothelioma research.
Who can apply
- Special district governments
- Public housing authorities/Indian housing authorities
- County governments
- Small businesses
- For profit organizations other than small businesses
- State governments
- Independent school districts
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Native American tribal organizations (other than Federally recognized tribal governments)
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
- Public and State controlled institutions of higher education
- Private institutions of higher education
- Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
- City or township governments
- Native American tribal governments (Federally recognized)
Applicant institution must have an established registry and tissue bank with the capability of functioning as a national virtual registry and tissue bank for mesothelioma, one in which participating institutions will make available their independent stores of mesothelioma tissue for public access and use through a centralized Internet-based database or registry. This virtual registry and tissue bank must be able to provide a resource for investigators engaged in the research of mesothelioma, to include, but not limited to, biospecimens (blood, plasma, white blood cells, and normal and malignant mesothelioma tissues) together with demographic data such as age, sex, race, occupational history and other epidemiologic information, and clinical data (stage, treatment and survival information).Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the HHS Grants Policy Statement, are not allowed.
How to apply
Applications go through the official government listing. Grants Radar links you straight to the source — applying is free.
New to federal funding? How to read an announcement · Who can apply · How grants work
Get grants like this every Tuesday — free
One email a week: the biggest new federal grants and what’s closing soon — the same list for everyone. Unsubscribe in one click.
Similar grants
- Feasibility Clinical Trials of Mind and Body Interventions for NCCIH High Priority Research Topics (R34 Clinical Trial Required)
- Investigator Initiated Clinical Trials of Complementary and Integrative Interventions Delivered Remotely or via mHealth (R01 Clinical Trial Required)
- Limited Competition: Small Grant Program for the NCATS Clinical and Translational Science Award (CTSA) Program (R03 Clinical Trial Optional)
- Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)
- Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)
- Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed)
Same-day alerts, matched to you
The free digest is weekly — the same list for everyone. Members get an alert the day a matching federal grant posts: we read every new Grants.gov posting and score it, personalized to your organization. Free for 30 days, then $19/mo founding rate locked for life — the rate holds while your subscription stays active (Terms). Card required, cancel any time before day 31.
See pricing